Please login to the form below

Not currently logged in
Email:
Password:

New Accounts: August - PR and Medical Eduction

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period May to July 2006 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period May to July 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

Abbott Laboratories

Humira

Rheumatoid arthritis

Succinct Communications

Apitope Technology

Phase Ib/IIa therapeutic biological vaccine

MS

Healthcare Solutions

Department of Health

GP educational tool

Oncology

Succinct Communications

Ferring Global

Glypressin

Cardiovascular

Lowe Fusion

GE Healthcare

DatSCAN

Diagnostic/neurology

Big Pink

GlaxoSmithKline Europe

Avandamet

Diabetes

Virgo Health PR

Kimberly-Clark

InteguSeal

Antimicrobial surgical skin preparation

De Facto Medica

Link Pharmaceuticals

Gliadel implant

Oncology

Spink Consumer Relations

Merck Sant?

Glucovance

Type II diabetes

De Facto Medica

Pfizer

Detrusitol

Genito-urinary

Big Pink

Plethora/Timm

Osbon ErecAid

Male sexual dysfunction

De Facto Medica

ProStrakan

Rapinyl

Breakthrough pain

Litmus/CCA

Roche Pharmaceuticals

Fuzeon/Invirase

HIV

Aurora

Servier

Various

Cardiology

Zaicom MMC

Speedel

SPP301

Hypertension

De Facto Medica

UCB

Confidential

Confidential

Virgo Health PR

UCB

Professional development programme

ADHD

Huntsworth Health Avenue

UCB

Xyzal

Allergy

Aurora

Wyeth Consumer Health

Anadin

Analgesics

Spink Consumer Relations

 

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics